A phase 2b, randomised double blind placebo controlled multicentre study to evaluate the effects of pentosan polysulfate sodium on treating pain in subjects with osteoarthritis of the knee and subchondral bone marrow lesions
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Oct 2018
At a glance
- Drugs Pentosan polysulfate (Primary)
- Indications Pain
- Focus Therapeutic Use
- Acronyms PARA005
- Sponsors Paradigm Biopharma
- 06 Aug 2018 Actual date last participant enrolled was 8/2/2018
- 06 Aug 2018 Planned End Date changed from 18 Dec 2018 to 2 Feb 2019.
- 06 Aug 2018 Status changed from recruiting to active, no longer recruiting.